Expertise in
14
conditions

Dr. Elizabeth Volkmann

Rheumatology
Ronald Reagan UCLA Medical Center
757 Westwood Plz, 
Los Angeles, CA 
Offers Telehealth
18 Years of Experience
Expertise in
14
conditions
Ronald Reagan UCLA Medical Center
757 Westwood Plz, 
Los Angeles, CA 

Overview

Elizabeth Volkmann is a Rheumatologist in Los Angeles, California. Dr. Volkmann has been practicing medicine for over 18 years is highly rated in 14 conditions, according to our data. Her top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Scleroma, and Sarcoidosis.

Her clinical research consists of co-authoring 143 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Year

2008

Specialties

Rheumatology

Licenses

Internal Medicine in CA

Hospital Affiliations

Ronald Reagan UCLA Medical Center

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Ronald Reagan UCLA Medical Center
757 Westwood Plz, Los Angeles, CA 90095
Other Locations
UCLA Health Westlake Village Triunfo Primary & Specialty Care
141 Triunfo Canyon Rd # 110, Westlake Village, CA 91361

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis
A Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: March 06, 2025
Intervention Type: Drug
Study Drug: HZN-825
Study Phase: Phase 2
A Phase 1 Open-Label Study to Determine the Safety and Tolerability of AVID200: A Transforming Growth Factor β (TGFβ) Inhibitor, in Patients With Diffuse Cutaneous Systemic Sclerosis
A Phase 1 Open-Label Study to Determine the Safety and Tolerability of AVID200: A Transforming Growth Factor β (TGFβ) Inhibitor, in Patients With Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Completed
Publish Date: November 19, 2024
Intervention Type: Drug
Study Drug: AVID200 TGFBeta Inhibitor
Study Phase: Phase 1
A Phase 2, Randomized, Placebo-controlled, Double-blind, Open-label Extension Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil (KD025) in Subjects With Diffuse Cutaneous Systemic Sclerosis
A Phase 2, Randomized, Placebo-controlled, Double-blind, Open-label Extension Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil (KD025) in Subjects With Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: August 30, 2023
Intervention Type: Drug
Study Drug: Belumosudil (KD025)
Study Phase: Phase 2
A Phase 2, Open-label Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
A Phase 2, Open-label Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Enrollment Status: Terminated
Publish Date: June 05, 2023
Intervention Type: Drug
Study Drug: Belumosudil
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
Enrollment Status: Completed
Publish Date: August 16, 2022
Intervention Type: Drug
Study Drug: Lenabasum
Study Phase: Phase 3
View 4 Less Clinical Trials

143 Total Publications

Type III and type VI collagen neoepitopes are associated with disease severity in systemic sclerosis.
Type III and type VI collagen neoepitopes are associated with disease severity in systemic sclerosis.
Journal: The Journal of rheumatology
Published: November 15, 2025
Similar Doctors
Expertise in
21
conditions
Dr. Tanaz A. Kermani
Rheumatology
Expertise in
21
conditions
Dr. Tanaz A. Kermani
Rheumatology
2020 Santa Monica Boulevard, Suite 540, 
Santa Monica, CA 
 (0.1 miles away)
310-582-6350
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Tanaz Kermani is a Rheumatologist in Santa Monica, California. Dr. Kermani is highly rated in 21 conditions, according to our data. Her top areas of expertise are Temporal Arteritis, Giant Cell Arteritis (GCA), Vasculitis, and Takayasu Arteritis. Dr. Kermani is currently accepting new patients.

Expertise in
22
conditions
Dr. Daniel Wallace
Rheumatology
Expertise in
22
conditions
Dr. Daniel Wallace
Rheumatology

Daniel J. Wallace M D A Medical Corp.

8750 Wilshire Blvd Ste 210, 
Beverly Hills, CA 
 (6.1 miles away)
310-652-0920
Languages Spoken:
English
See accepted insurances

Daniel Wallace is a Rheumatologist in Beverly Hills, California. Dr. Wallace is highly rated in 22 conditions, according to our data. His top areas of expertise are Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Sjogren Syndrome, and Rheumatoid Arthritis (RA).

Expertise in
8
conditions
Dr. Christina Charles
Rheumatology
Expertise in
8
conditions
Dr. Christina Charles
Rheumatology

Office

1000 Veteran Ave Rm 32-59, 
Los Angeles, CA 
 (3.6 miles away)
310-206-5366
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Dr. Christina Charles-Schoeman, MD is a Rheumatology Specialist in Los Angeles, CA. Dr. Charles-Schoeman has extensive experience in Rheumatologic Muscular Diseases and Osteoporosis & Screening. She is affiliated with Ronald Reagan UCLA Medical Center. Dr. Charles is highly rated in 8 conditions, according to our data. Her top areas of expertise are Dermatomyositis, Polymyositis, Myositis, and Rheumatoid Arthritis (RA).

Frequently Asked Questions about Dr. Elizabeth Volkmann

How do I make an appointment with Dr. Elizabeth Volkmann?

You can book an appointment with Dr. Elizabeth Volkmann by calling their office at 310-267-9643. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Elizabeth Volkmann a top-rated expert for Systemic Sclerosis (SSc)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Elizabeth Volkmann is classified as an Elite expert for Systemic Sclerosis (SSc), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Elizabeth Volkmann specialize in?

While Dr. Elizabeth Volkmann is a Rheumatology, they have specific expertise in Systemic Sclerosis (SSc), Scleroderma, and Scleroma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Elizabeth Volkmann participate in research or clinical trials?

Yes. Dr. Elizabeth Volkmann has published 143 articles and abstracts on conditions like Systemic Sclerosis (SSc). You can view a list of Dr. Elizabeth Volkmann's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Elizabeth Volkmann accept my insurance?

Dr. Elizabeth Volkmann accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 310-267-9643 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Volkmann's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 15 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile